ACR Meeting Abstracts

ACR Meeting Abstracts

Session » 3S075: Fibromyalgia & Other Clinical Pain Syndromes (827–832)

Date: Sunday, November 10, 2019

Time: 2:30PM-4:00PM

Meeting: 2019 ACR/ARP Annual Meeting

Abstract Number: 827
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Bedtime Sublingual Cyclobenzaprine (TNX-102 SL) for the Treatment of Fibromyalgia (FM): Evidence for a Broad Spectrum of Activity on the FM Syndrome
Abstract Number: 828
A Path Model Analysis of the Cognitive Determinants of Physical Activity Among Patients with Fibromyalgia (FM)
Abstract Number: 829
Dietary Intake Does Not Explain Microbiome Alterations or Symptom Severity in Fibromyalgia
Abstract Number: 830
The Efficacy of Non-Pharmacological Interventions for Fibromyalgia: A Systematic Review with Meta-Analysis
Abstract Number: 831
Maintaining Musculoskeletal Health: A Randomized Controlled Prevention Trial Amongst People at High Risk of Developing Chronic Widespread Pain
Abstract Number: 832
Diagnosis of Fibromyalgia: Comparison of AAPT and ACR Criteria

« View all sessions from this meeting